Cargando…

Histoplasmosis in an off-trail Hiker receiving ustekinumab: Implications for Preventive and diagnostic strategies for patients receiving anti-IL-12/23 therapy

Ustekinumab, an IL-12/23 inhibitor, is an important agent in treatment of inflammatory bowel disease and psoriasis. Clinical trials have not demonstrated significantly increased infection risk with ustekinumab. We report a case of disseminated histoplasmosis in the setting of ustekinumab and methotr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yun-Han, Magleby, Reed, Rao, Rema, Walsh, Thomas J., Singh, Harjot K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010353/ https://www.ncbi.nlm.nih.gov/pubmed/33816098 http://dx.doi.org/10.1016/j.mmcr.2021.03.004

Ejemplares similares

Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab
por: Pugliese, Daniela, et al.
Publicado: (2022)

Analgesic agents administered by ambulance personnel to mountain bikers and hikers on trails in Western Australia
por: Braybrook, Paul J., et al.
Publicado: (2023)

Supersymmetry for Alp Hikers
por: Ellis, John R.
Publicado: (2002)

Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis
por: Saur, Sebastian-Jonas, et al.
Publicado: (2021)

The Recreational Trail of the El Caminito del Rey Natural Tourist Attraction, Spain: Determination of Hikers’ Flow
por: Gea-García, Gemma María, et al.
Publicado: (2021)

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events
por: Gu, Stephanie L., et al.
Publicado: (2023)

Notes from the Field: Gastrointestinal Illness Among Hikers on the Pacific Crest Trail — Washington, August–October 2022
por: Hamlet, Arran, et al.
Publicado: (2023)

Staphylococcus aureus bacteremia with iliac artery endarteritis in a patient receiving ustekinumab
por: Joost, Insa, et al.
Publicado: (2016)

Profiles of Wellbeing in Soft and Hard Mountain Hikers
por: Próchniak, Piotr
Publicado: (2022)

Hiker's Feet: Hidden Warning Skin Sign
por: Saraya, Takeshi, et al.
Publicado: (2022)

Indirect Regulation and Equilibrium of p35 and p40 Subunits of Interleukin (IL)-12/23 by Ustekinumab in Psoriasis Treatment
por: Zhou, Jiong, et al.
Publicado: (2020)

Sorption of Interleukins 12 and 23 Using the Developed Magnetocontrollable Ustekinumab-Based Sorbent
por: Gontar, I.P., et al.
Publicado: (2020)

Ustekinumab in Psoriasis Immunopathology with Emphasis on the Th17-IL23 Axis: A Primer
por: Quatresooz, Pascale, et al.
Publicado: (2012)

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
por: Koutruba, Nora, et al.
Publicado: (2010)

Disseminated histoplasmosis and hemophagocytic lymphohistiocytosis in a patient receiving TNF-alpha inhibitor therapy
por: Zhong, Qiaonan, et al.
Publicado: (2022)

Effects of ozone and other pollutants on the pulmonary function of adult hikers.
por: Korrick, S A, et al.
Publicado: (1998)

Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results
por: Smolen, Josef S, et al.
Publicado: (2021)

Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis
por: Burlando, Martina, et al.
Publicado: (2020)

Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn’s disease receiving ustekinumab
por: Zhou, Longyuan, et al.
Publicado: (2023)

Persistent Headaches in an Avid Hiker: A Case of Chronic Coccidioidal Meningitis
por: Bies, Jared J, et al.
Publicado: (2023)

IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt
por: Fiechter, Renée H., et al.
Publicado: (2021)

Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study
por: Gossec, Laure, et al.
Publicado: (2023)

Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data
por: Van Kuijk, Arno W R, et al.
Publicado: (2023)

The Association between Regional Fat Distribution and Acute Mountain Sickness in Young Hikers
por: Dobrosielski, Devon A., et al.
Publicado: (2017)

Neuralgic Amyotrophy in a 66-year-old Hiker: a Case Report
por: Jahic, Dzenan, et al.
Publicado: (2019)

Personal Resources of Winter and Summer Hikers Visiting the Tatra National Park, Poland
por: Próchniak, Piotr, et al.
Publicado: (2022)

The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation
por: Chognard, Gaëlle, et al.
Publicado: (2014)

Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Bai, Fan, et al.
Publicado: (2019)

Decreased cortisol among hikers who preferentially visit and value biodiverse riparian zones
por: Opdahl, Ellie, et al.
Publicado: (2021)

Sudden Cardiac Death Risk in Downhill Skiers and Mountain Hikers and Specific Prevention Strategies
por: Niebauer, Josef, et al.
Publicado: (2021)

Motivation and mental well-being of long-distance hikers: A quantitative and qualitative approach
por: Mayer, Krisztina, et al.
Publicado: (2021)

Microcirculatory and Rheological Adaptive Mechanisms at High Altitude in European Lowlander Hikers and Nepalese Highlanders
por: Salvi, Paolo, et al.
Publicado: (2023)

Who behaves more pro-environmental in the national parks: A comparison of the tourist and the hiker
por: Zhang, Qing, et al.
Publicado: (2023)

Types and anatomical locations of injuries among mountain bikers and hikers: A systematic review
por: Braybrook, Paul John, et al.
Publicado: (2023)

Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
Publicado: (2020)

Fall-related accidents among hikers in the Austrian Alps: a 9-year retrospective study
por: Faulhaber, Martin, et al.
Publicado: (2017)

Future-Oriented Coping with Weather Stress among Mountain Hikers: Temperamental Personality Predictors and Profiles
por: Próchniak, Piotr, et al.
Publicado: (2021)

Long noncoding RNA HIKER regulates erythropoiesis in Monge’s disease via CSNK2B
por: Azad, Priti, et al.
Publicado: (2023)

Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
por: Xu, Mingli, et al.
Publicado: (2010)

Ozone and PM(2.5) Exposure and Acute Pulmonary Health Effects: A Study of Hikers in the Great Smoky Mountains National Park
por: Girardot, Steven P., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_7e5bbt9n4fi5sbravunp6kgskl